About Rubicon Research Limited
Rubicon Research Limited, established in 1999, is a specialty pharmaceutical formulations company committed to advancing global healthcare through innovative research and development. Headquartered in Thane, India, the company has expanded its development and manufacturing operations to Canada and multiple locations in India, serving diverse regulated markets worldwide. With a portfolio covering oral solids, liquids, nasal, ophthalmic, injectable, and topical products, Rubicon Research holds more than 50 patents and has commercialized over 70 products, including 66 US FDA-approved drugs as of June 2025. Its strategic approach combines proprietary technologies, robust product development capabilities, and a highly skilled team of scientists to address complex drug delivery challenges effectively. Rubicon Research has also invested in personal wellness, acquiring facilities and launching new subsidiaries to broaden its impact on consumer healthcare, making it a leader in pharmaceutical innovation and value-added development.
